FeesSafety
Pluang+

Magnera partners with U.S. Army to develop advanced battery separator tech for defense and commercial use

Market News
13 Oct 2026, 15:53 WIB
GlobeNewsWire
View Source
Bullish
Magnera partners with U.S. Army to develop advanced battery separator tech for defense and commercial use

Magnera Corporation has entered a Cooperative Research and Development Agreement with the U.S. Army Research Laboratory to advance next-generation battery separator technology using its OmniSep™ platform. This collaboration aims to improve battery performance, safety, and reliability for military and commercial applications, supporting energy resilience in power-intensive defense systems. The initiative also emphasizes domestic manufacturing and secure supply chains, aligning with national security and infrastructure modernization goals. This partnership could accelerate innovation in energy storage critical to future defense and commercial technologies.

Magnera Corporation's new research partnership is noted alongside Pluang's Basic Materials sector data. For readers following this sector, here is Pluang's market snapshot as of Oct 13, 2026 19:12 WIB: out of 62 priced stocks, 38 rose and 20 fell. Notable movers include Standard Lithium Ltd (SLI) at USD 1.51 with a 1-day change of +1.34%, International Flavors & Fragrances Inc. (IFF) at USD 86.03 up 1.26%, and Iamgold Corporation (IAG) at USD 18.80 up 1.24%. Typical hold times vary from 4 to 24 days, with SLI showing a Pluang order activity of 81% Sell and 19% Buy.

More News

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...

Company Fundamentals
Bullish
41 minutes ago
UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...

Neutral
41 minutes ago
Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App